- Papers in database
- 9
- Primary author
- 4 papers
- Years active
- 2017 – 2026
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (9)
- 2026Peptidoglycan from <i>Bifidobacterium bifidum</i> G9-1 induces IgA secretion in Peyer's patch-derived cells.10.12938/bmfh.2025-040
- 2025Bifidobacterium bifidum G9-1 Survives in the Intestinal Environment and Influences the Gut Microbiota Despite the Presence of Antimicrobials.10.1111/1348-0421.13230
- 2022Primary authorCorrection: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.10.1371/journal.pone.0267927
- 2021Primary authorImprovement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis10.1371/journal.pone.0248584
- 2021Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats10.3390/biomedicines9060641
- 2020Primary authorBifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action10.12938/bmfh.2019-022
- 2018Primary authorAlleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis10.12938/bmfh.18-020
- 2018Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats10.1038/s41598-018-30943-3
- 2017Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors10.1371/journal.pone.0173979